Characterization of The R6/1 Mouse Model of Huntington’s Disease
The B6.Cg-Tg(HD exon1)61Gpb/J mouse line, or R6/1, is a Huntington’s disease model that carries the human huntingtin gene’s 5’ end...
Phenotyping of a TDP-43 Mouse Model of ALS
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of upper and lower motor neurons producing...
Preclinical Acute Pain Studies
PsychoGenics excels in preclinical acute pain studies, employing reliable and validated models to assess pain thresholds and evaluate potential analgesic...
Preclinical Anxiety Studies
PsychoGenics consistently delivers high-quality preclinical anxiety studies using a diverse range of models and tests. With advanced technology and expertise,...
Preclinical Fragile X Syndrome Studies
Fragile X syndrome is a genetic disorder caused by a CGG expansion in the FMR1 gene. This condition tends to...
Characterization of a Mouse Model of Parkinson’s Disease
The Thy-1-α-synuclein mouse model of Parkinson’s disease is a transgenic mouse model that over-expresses wild-type human alpha-synuclein under the Thy1...
Preclinical Angelman Syndrome Studies
PsychoGenics is dedicated to supporting your research and advancing your program with tailored preclinical Angelman syndrome studies. Angelman syndrome is...
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Paterson, N. E.; Balci, F.; Campbell, U.; Olivier, B. E.; Hanania, T. J Psychopharmacol.2011 Doi: 10.1177/0269881110364272. Epub 2010 Mar 19....
High-throughput validation of ceRNA regulatory networks
Chiu H-S, Martínez M R, Bansal M, Subramanian S, Golub T R, Yang X, Sumazin P, Califano A . MicroRNAs...
Emer Leahy, Ph.D., MBA
Dr. Leahy received her Ph.D. in neuropharmacology from University College Dublin, Ireland, and her MBA from Columbia University. She is...